Axon Enterprise, Inc. boasts a unique, integrated ecosystem in public safety, with strong recurring revenue growth and expanding international opportunities. Despite robust fundamentals and management's confidence in software and services, the current valuation is excessively high, trading at over 100x forward FCF. My DCF analysis yields a fair value of $447 per share, well below the current market price, justifying a Sell rating.

CAVA's diverse menu, tech innovation, and loyalty program drive resilience and growth despite industry headwinds and a recent share price correction. Q2 showed slowing same-store sales, but revenue, profit margins, and restaurant count all grew, outperforming most fast casual peers. Valuation remains high versus the sector, but after a major correction, CAVA offers its best value since IPO and strong long-term expansion potential.

CULVER CITY, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, is postponing the conference call to discuss its financial results for the second quarter ended June 30, 2025, originally scheduled for later today, August 13, 2025, at 4:30 p.m. Eastern time.

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 10, 2025 to file lead plaintiff applications in a securities class action lawsuit against SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT), if they purchased the Company's securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”). This action is pending in t.

Healthcare has been one of the toughest sectors for investors over the past year. In fact, over the last 12 months, it has been the worst performing sector in the entire market.

Dell benefits from surging AI server demand and a growing partner base, but faces margin pressure and stiff competition.

Astera Labs, Inc. (ALAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Chain Bridge Bancorp, Inc. (CBNA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Columbia Banking (COLB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Integral Ad Science (IAS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

New York Times Co. (NYT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Ponce Financial (PDLB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Thryv Holdings, Inc. (THRY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

TowneBank (TOWN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Envista (NVST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Shares of Rigetti Computing Inc. NASDAQ: RGTI are down more than 2% the day after the quantum computing company delivered a mixed earnings report. Revenue of $1.8 million was roughly in line with expectations for $1.87 million.

DIS' multi-year NFL pact brings ESPN Draft rights, RedZone, and streaming tie-ins to Disney+ and Hulu, aiming to score big in sports streaming.

Bullish shares rocketed after the crypto exchange raised $1.1 billion in an initial public offering. The stock opened at $90 on the New York Stock Exchange under the ticker BLSH after its IPO priced at $37 per share.

American Well's revenue growth and cost control are strong, but the short DHA contract extension raises concerns about long-term stability and reliability of key revenue streams. Amwell's shift to higher-margin software revenue is promising, but guidance was revised downward due to contract uncertainties and program exclusions. Cost reductions have improved EBITDA and cash flow outlook, but excessive cuts risk undermining R&D, marketing, and future growth potential.

I rate Venture Global a 'Hold' due to strong LNG market growth offset by cyclical risks, overinvestment, and declining profitability metrics. Deregulation and global demand support revenue growth, but intense competition and potential overproduction threaten future pricing and margins. Profitability, ROIC, and free cash flow have deteriorated, while heavy debt and aggressive growth assumptions leave no room for execution missteps.